Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa
- PMID: 19615866
- DOI: 10.1016/j.ijantimicag.2009.06.007
Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa
Abstract
Efflux systems are thought to contribute to antimicrobial resistance in Pseudomonas aeruginosa. The mexAB-oprM deletion strain of P. aeruginosa PAO1 is compromised in its capacity to invade Madin-Darby canine kidney (MDCK) cells, suggesting that P. aeruginosa exports invasion determinants using a MexAB-OprM system. The influences of efflux pump inhibitors (EPIs), including the broad-spectrum EPI Phe-Arg-beta-naphthylamide (PAbetaN) and MexAB-OprM-specific EPI D13-9001, on the invasion of wild-type (WT) P. aeruginosa PAO1 and its MexAB-OprM-overproducing nalB strain were examined. The invasiveness of PAO1 WT and nalB strains was inhibited in the presence of EPIs in a concentration-dependent manner. Reduction of the invasiveness of both strains was greater for D13-9001 compared with PAbetaN. EPIs are thought to be useful in reducing the invasiveness and antimicrobial resistance of P. aeruginosa and thus may be promising as new anti-infectious agents.
Similar articles
-
An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).Phytomedicine. 2017 Dec 1;36:194-200. doi: 10.1016/j.phymed.2017.10.010. Epub 2017 Oct 12. Phytomedicine. 2017. PMID: 29157815
-
MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.Antimicrob Agents Chemother. 2007 Apr;51(4):1582-3. doi: 10.1128/AAC.01334-06. Epub 2007 Jan 12. Antimicrob Agents Chemother. 2007. PMID: 17220417 Free PMC article. No abstract available.
-
Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa.J Exp Med. 2002 Jul 1;196(1):109-18. doi: 10.1084/jem.20020005. J Exp Med. 2002. PMID: 12093875 Free PMC article.
-
Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions.Genet Mol Res. 2003 Mar 31;2(1):48-62. Genet Mol Res. 2003. PMID: 12917802 Review.
-
[Antibiotic efflux, a mechanism of multiple resistance in Pseudomonas aeruginosa].Bull Acad Natl Med. 1998;182(3):599-612; discussion 613-5. Bull Acad Natl Med. 1998. PMID: 9673055 Review. French.
Cited by
-
Co-development of efflux pump inhibitors with antibiotics on targeting structural and mutational aspects of AcrB subunit.Mol Divers. 2025 Apr 27. doi: 10.1007/s11030-025-11204-8. Online ahead of print. Mol Divers. 2025. PMID: 40287901
-
The intrinsic resistome of bacterial pathogens.Front Microbiol. 2013 Apr 30;4:103. doi: 10.3389/fmicb.2013.00103. eCollection 2013. Front Microbiol. 2013. PMID: 23641241 Free PMC article.
-
The rise and the fall of a Pseudomonas aeruginosa endemic lineage in a hospital.Microb Genom. 2021 Sep;7(9):000629. doi: 10.1099/mgen.0.000629. Microb Genom. 2021. PMID: 34473016 Free PMC article.
-
Resistance-Nodulation-Division Multidrug Efflux Pumps in Gram-Negative Bacteria: Role in Virulence.Antibiotics (Basel). 2013 Mar 18;2(1):163-81. doi: 10.3390/antibiotics2010163. Antibiotics (Basel). 2013. PMID: 27029297 Free PMC article. Review.
-
RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition.Front Microbiol. 2015 Apr 28;6:377. doi: 10.3389/fmicb.2015.00377. eCollection 2015. Front Microbiol. 2015. PMID: 25972857 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical